Verified Treatment Center
Lyle C Pearson
Mankato, MN · 56001
Key Takeaways for Lyle C Pearson
- • Outpatient · MAT offered
- • Accepts Medicare, Private insurance, TRICARE/VA
- • SAMHSA-listed facility
- • Direct line available · Helpline free & confidential 24/7
About Lyle C Pearson
Located in Mankato, MN, Lyle C Pearson operates within the MN regulatory framework as a licensed addiction-treatment provider. The facility's programming is outpatient (Outpatient, MAT), not residential. Structural evaluation of this facility's clinical posture requires review of state licensing records, accreditation status, and payer-network contracts.
Care levels at Lyle C Pearson
Lyle C Pearson is an outpatient-focused program (Outpatient, MAT) — patients live at home or in sober living and attend treatment sessions. This level of care is clinically appropriate for mild-to-moderate substance use disorder, or for patients stepping down from residential. Operational prerequisite for admission: documented clinical assessment establishing medical necessity for the specific level of care Lyle C Pearson provides. The ASAM Criteria 4e framework is the benchmark standard for this assessment and is referenced in most major payer medical-necessity documents.
Insurance and payment
Lyle C Pearson operates primarily on commercial insurance. The implication for patients: higher typical cost-share, potentially more intensive programming, and the full burden of MHPAEA parity-rule dynamics — including appeal rights when the plan denies. The facility also accepts TRICARE or military benefits. Benefit verification should be obtained in writing prior to admission and should document: network contract status for the specific insurance product, prior authorization requirements and approved day-count, applicable cost-sharing structure, and out-of-network secondary coverage (where applicable). Proceeding on verbal VOB creates material risk of post-admission benefit dispute.
Before you call
Pre-admission due-diligence for Lyle C Pearson: (1) ASAM 4e level-of-care documentation matching clinical assessment; (2) written Verification of Benefits specific to insurance product; (3) MAT policy documentation (particularly buprenorphine and methadone continuation protocols for opioid use disorder patients); (4) accreditation verification via CARF or Joint Commission provider-search tools; (5) state licensing status confirmed via MN behavioral-health regulator inspection records. The facility's documented pharmacotherapy offerings suggest MAT is available — confirm the specific medications and prescriber access during the admissions conversation.
Listing sourced from the SAMHSA Behavioral Health Treatment Services Locator. Data last synced April 2026. Verify current programs directly with the facility.
Lyle C Pearson at a Glance
Levels of care
Outpatient · MAT
Service settings
Outpatient, Outpatient methadone/buprenorphine or naltrexone treatment, Regular outpatient treatment
Therapy approaches
Anger management, Brief intervention, Cognitive behavioral therapy, Relapse prevention, Telemedicine/telehealth therapy, Trauma-related counseling
Age groups
Young Adults, Adults
Medications
Acamprosate (Campral®), Disulfiram, Buprenorphine with naloxone, Buprenorphine without naloxone, Naltrexone (oral), Naltrexone (extended-release, injectable)
Insurance & Payment Accepted
Confirm in-network status before admission — verification is free.
Medicaid
Medicare
Coverage details →Private insurance
Coverage details →TRICARE / VA
Coverage details →Contact & Location
Address
1400 Madison Avenue, Mankato, MN 56001
Facility direct line
507-387-2939Website
www.minneapolis.va.gov